Ionis

Ionis is a biopharmaceutical company that develops and commercializes drugs based on antisense technology.

Why it’s in the news: It is in the news due to its acquisition of a company developing an RNA-based therapy for amyotrophic lateral sclerosis (ALS).

Latest on Ionis

• China warns France, Germany against 'protectionist' trade tools
• UK Green Party adopts ‘Zionism is racism’ policy, drawing backlash from Israel
• Reflationists? Who, us? Heirs to Abenomics insist it’s a thing of the past.
• Japan’s finance chief says Takaichi isn’t ‘reflationist’
• AI vs agtech: How AI is revolutionising agriculture
• Private equity could revolutionise US lawyer pay, law firm bosses say

Connections

5 entities linked to Ionis across the news graph.